Dañino-García M, Domínguez-Cruz J J, Pérez-Ruiz C, Conejo-Mir J, Pereyra-Rodríguez J J
UGC Dermatología, Hospital Universitario Virgen del Rocío, Sevilla, España.
UGC Dermatología, Hospital Universitario Virgen del Rocío, Sevilla, España.
Actas Dermosifiliogr (Engl Ed). 2019 Jun;110(5):360-365. doi: 10.1016/j.ad.2018.09.007. Epub 2018 Oct 28.
Merkel cell carcinoma is a rare yet aggressive cutaneous tumor with a poor prognosis. Few studies have analyzed series of patients from the same hospital.
We performed a retrospective, descriptive, observational study of all patients diagnosed with Merkel cell carcinoma at a tertiary care hospital between 2002 and 2017. We recorded epidemiological, clinical, and histologic data and information on treatments and survival. For analysis, the sample was divided into 2 groups from different periods: 2002-2009 and 2010-2017. We performed survival analysis using Kaplan-Meier curves and multivariate analysis using a Cox proportional hazards model.
Thirty-eight patients (24 men and 14 women) with a mean age of 77.76 years were included. Mean follow-up time was 30.11 months. On comparing 2010-2017 with 2002-2009, we observed a 116% increase in the number of Merkel cell carcinoma cases (26 vs. 12), an older mean age at diagnosis (80.92 vs. 70.92 years, P<.05), and an increase in lesions located on the trunk and lower limbs (0% vs. 34.62%). Eleven patients died of Merkel cell carcinoma. Overall survival was 78.2% at 12 months and 69.3% at 24 months. In the univariate analysis, age over 70 years and lymph node involvement were associated with mortality, while tumor location on the upper extremities and wide surgical excision were associated with improved survival. Only lymph node involvement retained its prognostic significance in the multivariate analysis.
In this series, we observed that Merkel cell carcinoma has become more common in recent years and is now diagnosed at an older age and found in new anatomic locations.
默克尔细胞癌是一种罕见但侵袭性强的皮肤肿瘤,预后较差。很少有研究分析来自同一家医院的患者系列。
我们对2002年至2017年期间在一家三级护理医院被诊断为默克尔细胞癌的所有患者进行了一项回顾性、描述性、观察性研究。我们记录了流行病学、临床和组织学数据以及治疗和生存信息。为了进行分析,样本被分为两个不同时期的组:2002 - 2009年和2010 - 2017年。我们使用Kaplan - Meier曲线进行生存分析,并使用Cox比例风险模型进行多变量分析。
纳入了38例患者(24例男性和14例女性),平均年龄为77.76岁。平均随访时间为30.11个月。将2010 - 2017年与2002 - 2009年进行比较时,我们观察到默克尔细胞癌病例数增加了116%(26例对12例),诊断时的平均年龄更大(80.92岁对70.92岁,P <.05),并且位于躯干和下肢的病变增加(0%对34.62%)。11例患者死于默克尔细胞癌。12个月时的总生存率为78.2%,24个月时为69.3%。在单变量分析中,70岁以上年龄和淋巴结受累与死亡率相关,而上肢肿瘤位置和广泛手术切除与生存率提高相关。在多变量分析中,只有淋巴结受累保留了其预后意义。
在本系列研究中,我们观察到默克尔细胞癌近年来变得更加常见,现在诊断时年龄更大且在新的解剖部位发现。